Skip to main content
NCBI home page
Dose-Response logoLink to Dose-Response
. 2020 Jul 24;18(3):1559325820942077. doi: 10.1177/1559325820942077

Antihypertensive and Antihyperlipidemic Activity of Aqueous Methanolic Extract of Rauwolfia Serpentina in Albino Rats

Syed Muhammad Ali Shah 1,✉, Syed Ali Raza Naqvi 2,✉, Naveed Munir 3, Sohaib Zafar 2, Muhammad Akram 1, Jaweria Nisar 1
PMCID: PMC7383702  PMID: 32782448

Abstract

Rauwolfia serpentina has a wide range of therapeutic effects so this study was planned to explore the antihypertensive and antihyperlipidemic therapeutic responses of R serpentina doses using albino rats by measuring the blood pressure, biochemical parameters, and histological architecture of liver and kidney tissues. Thirty albino rats were divided into 5 groups (n = 6) as G1 (normal Control) received normal diet, G2 (positive control) received only 8% NaCl added diet (high salt diet); G3 was given atenolol (standard drug control) 50 mg/kg body weight, G4 and G5 groups were given methanolic plant extract as low dose (100 mg/kg body weight) and high dose (200 mg/Kg body weight) daily along with high salt diet for 4 weeks, respectively. Rauwolfia serpentina significantly (P < .05) decreased the blood pressure in G4 and G5 groups as compared to G2 and G3. Significant (P < .05) impact was reported, on serum lipid profile and serum proteins as well as hepatoprotective and renoprotective potential on studying tissues sections under microscope, in animal groups given herbal extract as compared to control groups. It could be concluded that R serpentina has therapeutic effect to manage the hypertension and hypercholesterolemia most probably via protecting the liver and renal architectures.

Keywords: Rauwolfia serpentina, herbal medicine, hypertension, hypercholesterolemia, therapeutic response, different doses

Introduction

Rauwolfia serpentina is used as drug since ancient times. Rauwolfia serpentina belongs to family Apocynaceae. There were still about 121 chemical substances identified from different medicinal plant which are used throughout the world.1 Rauwolfia serpentina is perceived as Rauwolfia in Hindi, Hindustani Snake Root in English, Amalpori in Malayalam, Chandra in Bengali, and so forth. It is a sage of restorative worth marked in ayurvedic, western arrangement of prescription. Its leaves, seeds, roots, and organic products are used in the cure of numerous disorders. Rauwolfia serpentina contains many phytochemical compounds including flavonoids, alkaloids, tannins, and phenols.2 Flavonoids have a wide range of therapeutic applications and are being utilized for more than one billion years to treat hypertensive activity.3 Rauwolfia serpentina possesses the alkaloid reserpine that is useful agent to treat the blood pressure and other neurological diseases.4 Reserpine produces its antihypertensive effect by binding to the catecholamine in the nerve cells.5 Suggestions includes, it leads to depress the central nervous system and peripheral nervous system. Reserpine also activates the parasympathetic system by neurotransmitter substance depletion from the adrenergic neurons.4,6 The drug R serpentina is used to treat many neurological disorders including vertigo, insomnia, schizophrenia, and sexual aggression.6 The drug acts as hypnotic, sedative, antihypertensive, and antihypercholesteremic. Its leaves and root extract can be used to relief stomach pain, liver pain, dysentery, and to expel intestinal worms.2,7 It is utilized in the management of hypertension, arrhythmia, human promyelocytic leukemia, pneumonia, asthma, AIDS, spleen disorders, and skin illnesses.6,8,9 The present study was planned to evaluate the R serpentina therapeutic potential in the treatment of hypertension and hypercholesterolemia induced in animal model.

Material and Methods

Preparation of Plant Extract

Rauwolfia serpentina roots were bought from local market of Faisalabad and taxonomically authenticated from Department of Botany, Government College University, Faisalabad, Pakistan. To clean or rid the roots of the sample plants of impurities, fresh water and later distilled water were used to rinse them, the roots of the sample plant were dried under a shaded place avoiding direct sunlight. Then dried roots were grinded to make powder and save this powder in a glass jar under temperature 4 °C. Hydro-methanolic (30:70) was used as solvent for the extraction of roots of R serpentina. The plant materials were dissolved in extraction solvent at a ratio of 1:10 (wt/vol) and placed for 72 hours at room temperature in a shaker. Then, the mixture was filtered using Whatman filter paper No. 1. The extraction was repeated 3 times and the filtrate was collected in a beaker. Then the filtered extract was concentrated using rotary evaporator at 40 °C under vacuum.10 Then dry extract was stored in air tight polythene bags until the trial was run.

Experimental Design

Albino rats (n = 30) were used as experimental animals in this study weighing about 130 ± 20.5 g of 10 to 12 weeks of age. All rats were given a standard diet and water ad libitum and before start the trial, rats were acclimatized to handlers for 3 days. This study was approved from ethical review committee for research, Government College University, Faisalabad, Pakistan. The animals were divided randomly, made 5 groups having 6 rats (n = 6) in each group. First group G1 (normal control) received normal diet and water ad libitum, group G2 (positive control) received only 8% sodium chloride (NaCl) added diet (high salt diet), and group G3 was given allopathic drug atenolol (standard drug) orally at dosage 50 mg/kg body weight daily along high salt diet. Groups G4 and G5 were given methanolic plant extract with dosage as low dose (100 mg/kg body weight) and high dose (200 mg/kg body weight) daily along with high salt diet for 4 weeks, respectively.

Measurement of Blood Pressure

Tail-cuff method is noninvasive method used to measure systolic and diastolic blood pressure, heart rate, and temperature. Before blood pressure measurements, rats were kept in scanner for 30 minutes to warm them. Blood pressure was measured at the 0, 7, 15, and 30 days.

Blood Biochemical Parameters and Histopathological Studies

At the end of fourth week samples of blood were collected in clot activator vials by cardiac puncture. The serum was separated by centrifugation at 3000 rpm for 10 minutes. Serum biochemical analysis including total protein was measured by Biuret method, albumin by bromocresol green method11 and Serum globulin was determined using the formula given below

Serum globulin = Serum total protein - serum albumin

Albumin/globulin ratio was calculated by dividing the albumin concentration to globulin concentration. Cholesterol in the sample was determined quantitatively by cholesterol oxidase method using the commercially available kit spectrophotometrically.12 Triglyceride was measured using enzymatic kit method following the protocol of the study by Shephard and Whiting13 with the help of spectrophotometer. High-density lipoprotein (HDL)–Cholesterol was determined calorimetrically using the procedure described by Friedewald et al,14 and low-density lipoprotein (LDL)–Cholesterol and very low-density lipoprotein (VLDL)–Cholesterol were calculated using the formulas described by Friedewald et al,14 given below:

LDL-cholesterol (mg/dL) = Total cholesterol - (TG/5) - HDL-cholesterol.

Liver and kidney tissues were collected from the sacrifice rats for histopathological examination. The tissue sections were processed to embed in paraffin wax and the slides were prepared by staining with hematoxylin and eosin stain after microtomy and observed under light microscope to note any type of morphological changes in tissues as described in the study by Spencer et al.15

Statistical Analysis

All results were presented as mean ± standard error of mean. The obtained data were analyzed statistically using 1-way analysis of variance and Tukey test were used to determine pairwise comparison using statistical Software SPSS 23 (Trial version). P value <.05 was representing the significant difference between groups.

Results

Effect of R serpentina on Hypertension

The mean systolic and diastolic blood pressure were significantly (P < .05) decreased in groups G3, G4, and G5 as compared to G2 group throughout the experimental days. Moreover, results revealed that systolic and diastolic blood pressure was significantly (P < .05) lower in G4 and G5 group received R serpentina extracts as compared to G3 group given standard drug (Figures 1 and 2). Further, it was reported that there was a nonsignificant difference between control group (G1) and R serpentina treated group (G4 and G5) at the end of the experiment. Results also revealed that blood pressure in G4 and G5 was lower as compared to G3 group but the difference was not significant (P > .05) statistically. Pairwise study was also revealed the significance (P < .05) difference among different study groups represented by small alphabets (columns share the same letters represent nonsignificant (P > .05) difference) for more details please see all figures.

Figure 1.

Figure 1.

Open in a new tab

Means ± standard errors of mean of systolic blood pressure in different groups at specific intervals. Alphabets represent the pairwise comparison of groups (Bars bearing different letters are statistically, P < .05, differ).

Figure 2.

Figure 2.

Open in a new tab

Means ± standard errors of mean of diastolic blood pressure in different groups at specific intervals. Alphabets represent the pairwise comparison of groups (Bars bearing different letters are statistically, P < .05, differ).

Effect of R serpentina on Blood Biochemical Parameters

The results of present study showed significant (P < .05) reduction of total cholesterol (TC) and LDL-Cholesterol levels in G4 and G5 groups on given R serpentina extract for 4 weeks in contrast with the G2 group (Figures 3 and 4). High-density lipoprotein–Cholesterol level was significantly increase (P < .05) in G3, G4, and G5 groups in contrast with G2 group. It was also determined that R serpentina also have significant potential (P < .05) to regulate the serum VLDL-Cholesterol and triglyceride levels in G4 and G5 group. Further, the results of serum proteins were also revealed that R serpentina extracts induction increase the serum proteins in G4 and G5 but statistical analysis revealed a nonsignificant (P > .05) impact among the groups (Figure 5).

Figure 3.

Figure 3.

Open in a new tab

Means ± standard errors of mean of total cholesterol, LDL-Cholesterol, HDL-Cholesterol, and VLDL-Cholesterol in different groups. Alphabets represent the pairwise comparison of groups (Bars bearing different letters are statistically, P < .05, differ). HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.

Figure 4.

Figure 4.

Open in a new tab

Means ± standard errors of mean of triglyceride in different groups. Alphabets represent the pairwise comparison of groups (Bars bearing different letters are statistically, P < .05, differ).

Figure 5.

Figure 5.

Open in a new tab

Means ± standard errors of mean of serum total proteins, albumin, and globulin in different groups. Alphabets represent the pairwise comparison of groups (Bars bearing different letters are statistically, P < .05, differ).

Effect of R serpentina on Histopathology of Liver and Kidney

Histologic examination of the section from control group (G1) shows a liver tissue with intact architecture. No altered architecture is seen and the hepatocytes with typical cores, sinusoidal spaces, with Kupffer cells (Figure 6A). While G2 group liver section shows liver tissue with altered architecture, periportal necroinflammatory changes, portal inflammation, mild degenerative changes, congestion, and mild chronic inflammation (Figure 6B). Moreover, liver tissue sections from G3, G4, and G5 groups showed the preventive effect of extract on the architecture of liver and no critical change was reported under microscope (Figure 6C and D). Histological examination of the sections from the kidney comprises of cortex and medulla. There was minor harm of kidneys in G2 group (Figure 7B). There was minimal endothelial swelling and impediment of slim circles in G2 group. There was no critical impact of salt in G4 and G5 (Figure 7C and D).

Figure 6.

Figure 6.

Open in a new tab

Histopathology of liver tissue (A) represents the histopathology of control group (G1); (B) represents the histopathology of high salt diet group (G2) with histopathological alterations; (C) represents the histopathology of group (G3) with very minute cellular changes treated with atenolol; (D) represents the histopathology of high-dose extract treated group (G5).

Figure 7.

Figure 7.

Open in a new tab

Histopathology of kidney tissue (A) represents the histopathology of control group (G1); (B) represents the histopathology of salt diet group (G2); (C) represents the histopathology of group (G3) treated with atenolol; (D) represents the histopathology of high-dose extract treated group (G5).

Discussion

Hypertension is one of the important common global challenge in public health.16,17 It is the major risk of many diseases including stroke, heart failure, chronic liver failure, coronary artery disease, and retinopathy.18-21 Rauwolfia serpentina contained a wide range of phytochemical constituents such as alkaloids, flavonoids, phenolics, carbohydrates, tannins, and saponins.22 The most important alkaloids include reserpine, ajmalicine, serpentinine, ajmalimine, ajmaline, rescinnamidine, rescinnamine, reserpiline, serpentine, indobidine, yohimbine, and deserpidine. Reserpine acted as hypotensive agent by depleting the catecholamine and angiotensin-converting enzyme (ACE) is inhibited by rescinnamine to halt the conversion of angiotensin I, resulting in a decrease of plasma angiotensin II then lowering blood pressure. Sodium channel blockage is the major role of ajmaline to show antiarrhythmic effect of R serpentine.22,23 Yohimbine has role in the treatment of erectile dysfunction as it is selective alpha-adrenergic antagonist in blood vessels. Antidiabetic and hypolipidemic potential of R serpentina extract is due to the presence of high concentration of phenolic compounds. Antioxidant, anti-inflammatory, and anticancer activities of R serpentina are due to the presence of flavonoids.2 Cholesterol binding ability is due to the presence of saponins.23

The present study was conducted to explore the R serpentina effect for the management of hypertension and hypercholesterolemia in animal model. The result of the present study showed that R serpentina extract showed significant improvement in the blood pressure, lipid profile, and tissues histopathology as compared to the animal group receive the allopathic drug. Ranjini et al investigated the antihypertensive effect of aqueous extract of R serpentina leaves along with the Allium sativum cloves using animal models as sheep kidney and lung ACE. Hippuryl-hiatdyl-leucine method to measure the activity was used and the level of hippuric acid release was determined. The study revealed significant antihypertensive effect of R serpentine.24

It was reported that R serpentina contain very important alkaloid as reserpine that produces the antihypertensive effect. The researcher Shaman and Perez reported that reserpine at the dose of 0.5 mg/d able to reduce the blood pressure. They described that reserpine significantly declined the systolic and diastolic blood pressure.25 Globally, day by day, the occurrence of hyperlipidemia is increasing either due to unhealthy lifestyle or the genetic factor involvement.26 High cholesterol level in the blood is becoming one of the chief causes of mortality due to cardiac arrest worldwide27 and also has been reported in Pakistan.28,29 It was reported that root powder of R serpentina significantly reduced the serum lipids including TC, triglycerides (TG), LDL-C, and increased the HDL-C when given to rabbits orally for 12 days. Moreover, it also has hepatoprotective activities investigated by measuring the alanine aminotransferase, and lactate dehydrogenase.30 It was also reported that methanolic extract of R serpentina have antihyperglycemic, antiatherogenic, decreased coronary blockage risk, and cardioprotective indices in alloxan-induced diabetic mice.31 Recently, Azmi and Qureshi reported the lipid homeostasis effect of R serpentina. They reported that the drug significantly improved the lipid profile including TC, LDL, VLDL, HDL, and triglyceride. The results showed that herbal medicine significantly lowered the TC, LDL, VLDL, triglyceride level, and increased the HDL.32 Rauwolfia serpentina effect on kidney was controversial. Many researchers reported the effect of R serpentina on liver. Gupta et al demonstrated the hepatoprotective effect of R serpentina paracetamol induced damage. They described that R serpentina has the hepatoprotective activity due to its antioxidant property.3,33 In another study, Qureshi et al described the hepatoprotective, hypolipidemic, and hypoglycemic effect of the methanolic extract of the drug in diabetic-induced rats. The results of histopathology of liver in our study also showed the significant improvement between control group and extract-treated group.34 On the other hand, Mossoba et al described the vulnerable effect of R serpentina on kidney specifically proximal tubules of kidney. They explained that the drug produced the harm effects on renal system in vitro.35 However, the present study reported the no harm effect on kidney tissues. More research has been required to demonstrate the effect of R serpentina on kidney.

Conclusion

Although commercially available pharmaceutical products are used for the treatment of wide range of clinical conditions are available in market but the medicinal plants always remained as primary choice due to their safety as well as high efficacy. Rauwolfia serpentina is one of the natural herbal medicines with wide spectrum of therapeutic effects. The results of current study also revealed the hypotensive and hypolipidemic effect of methanolic extract of R serpentina in albino rats without any damage to liver and kidney. However, further research is required at large scale to isolate the phytochemical constituents responsible for its therapeutic and alongside side effect if any.

Acknowledgments

The authors thankful to “Eman Diagnostic Laboratories, Lahore-Pakistan (PHC Regd # R-14074)” and their technical staff to provide us technical assistance and guidance to complete this study.

Footnotes

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD: Syed Muhammad Ali Shah Inline graphic https://orcid.org/0000-0003-3825-5589

Muhammad Akram Inline graphic https://orcid.org/0000-0001-7863-8803

References

  • 1. Pandey V, Cherian E, Patani G. Effect of growth regulators and culture conditions on direct root induction of Rauwolfia serpentina L.(Apocynaceae) Benth by leaf explants. Trop J Pharm Res. 2010;9(1). [Google Scholar]
  • 2. Kumari R, Rathi B, Rani A, Bhatnagar S. Rauvolfia serpentina L. Benth. ex Kurz.: phytochemical, pharmacological and therapeutic aspects. Int J Pharm Sci Rev Res. 2013;23(2):348–355. [Google Scholar]
  • 3. Gupta J, Gupta A. Isolation and extraction of flavonoid from the leaves of Rauwolfia serpentina and evaluation of DPPH-scavenging antioxidant potential. Orient J Chem. 2015;31(special issue 1):231–235. [Google Scholar]
  • 4. Singh R, Singh A, Rath S, Ramamurthy A. A review on sarpagandha-Whole herb v/s reserpine–Its alkaloid in the management of hypertension. Int Ayur Med J. 2015;3:565–569. [Google Scholar]
  • 5. Bunney WE, Davis JM. Norepinephrine in depressive reactions: a review. Arch Gen Psychiatry. 1965;13(6):483–494. [DOI] [PubMed] [Google Scholar]
  • 6. Bunkar AR. Therapeutic uses of Rauwolfia serpentina . Int J Adv Sci Res. 2017;2(2):23–26. [Google Scholar]
  • 7. Ezeigbo I, Ezeja M, Madubuike K, et al. Antidiarrhoeal activity of leaf methanolic extract of Rauwolfia serpentina . Asian Pac J Trop Biomed. 2012;2(6):430–432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Soni R, Sakshi J, Bara JK, Saksena P. The use of Rauwolfia serpentina in hypertensive patients. J Biotechnol Biochem. 2016;2(5):28–32. [Google Scholar]
  • 9. Kostin YV, Melokhova E, Gendenshtein E, Volkova ND, Astakhova TV, Savel’eva EK. Antiarrhythmic activity of the total alkaloids from a Rauwolfia serpentina tissue culture. Pharm Chem J. 1986;20(3):214–217. [Google Scholar]
  • 10. Quintão FJ, Tavares RS, Vieira-Filho SA, Souza GHB, Santos ODH. Hydroalcoholic extracts of Vellozia squamata: study of its nanoemulsions for pharmaceutical or cosmetic applications. Revista Brasileira de Farmacognosia. 2013;23(1):101–107. [Google Scholar]
  • 11. Tietz N. Clinical Guide to Laboratory Tests. 3rd ed WB Saunders Co; 1995:186–188. [Google Scholar]
  • 12. Siedel J, Hägele E, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29(6):1075–1080. [PubMed] [Google Scholar]
  • 13. Shephard M, Whiting M. Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder’s chromogen. Clin Chem. 1990;36(2):325–329. [PubMed] [Google Scholar]
  • 14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. [PubMed] [Google Scholar]
  • 15. Spencer LT, Bancroft JD, Jones WG. Tissue Processing. Bancroft’s Theory and Practice of Histological Techniques, Expert Consult: Online and Print. Elsevier Health Sciences; 2012:7. [Google Scholar]
  • 16. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369. [DOI] [PubMed] [Google Scholar]
  • 17. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a systematic review. Hypertension. 2007;50(6):1012–1018. [DOI] [PubMed] [Google Scholar]
  • 18. Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD. Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr Hypertens Rep. 2012;14(3):247–253. [DOI] [PubMed] [Google Scholar]
  • 19. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810–817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. de Faria JBL, Silva KC, de Faria JML. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. 2011;34(4):413–422. [DOI] [PubMed] [Google Scholar]
  • 21. Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN. Changes in fitness and fatness on the development of cardiovascular disease risk factors: hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol. 2012;59(7):665–672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Agrawal S. Rauvolfia serpentina: a medicinal plant of exceptional qualities. Alt Med Chiropr OA J. 2019;2(2):180016. [Google Scholar]
  • 23. Kaur A. Pharmacobotanical and pharmacological evaluation of ayurvedic crude drug: Rauwolfia serpentina (Apocynaceae). Int J Green Pharm. 2018;11(4): S686–89. [Google Scholar]
  • 24. Ranjini H, Udupa PE, Thomas JM. Angiotensin converting enzyme (ACE): inhibition of sheep kidney and lung ACE in vitro by Rauwolfia serpentina and allium sativum. Sch J App Med Sci. 2015;3(5):1936–1940. [Google Scholar]
  • 25. Shamon SD, Perez MI. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst Rev. 2016;12(12):CD007655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. El-Hazmi MA, Warsy AS. Prevalence of plasma lipid abnormalities in Saudi children. Ann Saudi Med. 2001;21(1-2):21–25. [DOI] [PubMed] [Google Scholar]
  • 27. Aziz K, Aziz S, Faruqui A, et al. Evaluation and comparison of coronary heart disease risk factor profiles of children in a country with developing economy. J Pak Med Assoc. 2004;54(7):364–371. [PubMed] [Google Scholar]
  • 28. Jafary MH, Samad A, Ishaq M, Jawaid SA, Ahmad M, Vohra EA. Profile of acute myocardial infarction (AMI) in Pakistan. Pak J Med Sci. 2007;23(4):485. [Google Scholar]
  • 29. Iqbal S, Dodani S, Qureshi R. Risk factors and behaviours for coronary artery disease (CAD) among ambulatory Pakistanis. J Pak Med Assoc. 2004;54(5):261–266. [PubMed] [Google Scholar]
  • 30. Qureshi SA, Udani SK. Hypolipidaemic activity of Rauwolfia serpentina Benth. Pak J Nutr. 2009;8(7):1103–1106. [Google Scholar]
  • 31. Azmi MB, Qureshi SA. Methanolic root extract of Rauwolfia serpentina benth improves the glycemic, antiatherogenic, and cardioprotective indices in alloxan-induced diabetic mice. Adv Pharmacol Sci. 2012;2012:376429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Azmi MB, Qureshi SA. Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice. Pak J Pharm Sci. 2016;29(5):1619–1624. [PubMed] [Google Scholar]
  • 33. Gupta AK, Chitme H, Dass SK, Misra N. Hepatoprotective activity of Rauwolfia serpentina rhizome in paracetamol intoxicated rats. J Pharmacol Toxicol. 2006;1(1):82–88. [Google Scholar]
  • 34. Qureshi S, Nawaz A, Udani S, Azmi B. Hypoglycaemic and hypolipidemic activities of Rauwolfia serpentina in alloxan-induced diabetic rats. Int J Pharmacol. 2009;5(5):323–326. [Google Scholar]
  • 35. Mossoba ME, Flynn TJ, Vohra S, Wiesenfeld PL, Sprando RL. Human kidney proximal tubule cells are vulnerable to the effects of Rauwolfia serpentina . Cell Biol Toxicol. 2015;31(6):285–293. [DOI] [PubMed] [Google Scholar]

Articles from Dose-Response are provided here courtesy of SAGE Publications

RESOURCES